Cargando…
MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells
BACKGROUND: Melanoma is notoriously resistant to all current modalities of cancer therapies including chemotherapy. In recent years, microRNAs (miRNAs) have emerged as molecular regulators in the development and progression of melanoma. However, the relationship between microRNA and chemo-resistance...
Autores principales: | Li, Yuxia, Zhang, Jie, Liu, Yajing, Zhang, Bingyue, Zhong, Fubo, Wang, Shubin, Fang, Zhengyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896053/ https://www.ncbi.nlm.nih.gov/pubmed/29642855 http://dx.doi.org/10.1186/s12885-018-4233-9 |
Ejemplares similares
-
miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
por: Wang, Yunjiang, et al.
Publicado: (2021) -
MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer
por: Su, Jiaojiao, et al.
Publicado: (2014) -
Salinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux
por: Liu, Yajing, et al.
Publicado: (2020) -
MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
por: Jia, Cheng You, et al.
Publicado: (2011) -
miR-193b and miR-30c-1(*) inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
por: Kordaß, Theresa, et al.
Publicado: (2018)